Myriad Genetics Reports Fiscal Fourth-Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. SPCX
2. NVDA
3. NFLX
4. META
5. TSLA
6. ISRG
7. SMCI
8. RTX
9. S
10. COF

Go back to Myriad Genetics Reports Fiscal Fourth-Quarter 2020 Financial Results

Myriad Genetics (MYGN) Tops Q4 EPS by 16c

August 13, 2020 4:12 PM EDT

Myriad Genetics (NASDAQ: MYGN) reported Q4 EPS of ($0.31), $0.16 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $93.2 million versus the consensus estimate of $93.85 million.

"Following the substantial decline in test volumes at the end of Q3 and beginning... More